About Raymond Zheng
Form D filings for Urica Therapeutics in 2023 list Raymond Zheng as executive officer and director.
Raymond Zheng first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Raymond Zheng in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Raymond Zheng works with at each company, as listed on that company's latest Form D.
Urica Therapeutics, Inc. · Form D, Jan 5, 2023
JD
Jay Kranzler, M.D., Ph.D.
Executive officer and director
MW
Michael Weiss
Director
VD
Vibeke Strand, M.D.
Director
LD
Lindsay Rosenwald, M.D.
Director